[1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 Jan;87(1):4-14. DOI: 10.1016/j. diabres.2009.10.007]Search in Google Scholar
[2. Green A, Patterson CC; EURODIAB TIGER Study Group. Europe and Diabetes. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia. 2001 Oct;44(Suppl 3):B3-8. DOI: 10.1007/ PL0000295010.1007/PL00002950]Search in Google Scholar
[3. Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, et al. Heterogeneity of type I diabetes: Analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001 Mar;44(3):354-62. DOI: 10.1007/s00125005162610.1007/s001250051626]Search in Google Scholar
[4. Atkinson M, Eisenbarth G. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001 Jul;358(9277):221-9. DOI: 10.1016/S0140-6736(01)05415-010.1016/S0140-6736(01)05415-0]Search in Google Scholar
[5. The Diabetes Prevention Trial-Type 1 Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002 May;346(22):1685-91. DOI: 10.1056/NEJMoa01235010.1056/NEJMoa01235012037147]Search in Google Scholar
[6. Lenze S. The mechanisms of alloxan- and streptozotocin- induced diabetes. Diabetologia. 2008 Feb;51(2):216-26. DOI: 10.1007/s00125-007-0886-710.1007/s00125-007-0886-718087688]Search in Google Scholar
[7. Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ. 2003;12(1):44-50. DOI: 10.1046/j.1444-2892.2003.00160.x10.1046/j.1444-2892.2003.00160.x16352106]Search in Google Scholar
[8. Bahey NG, Soliman GM, El-Deeb TA, El-Drieny EA. Influence of insulin and testosterone on diabetic rat ventral prostate: Histological, morphometric and immunohistochemical study. Journal of Microscopy and Ultrastructure. 2014;2(3):151-60. DOI: 10.1016/j. jmau.2014.06.002]Search in Google Scholar
[9. Moorhead KT, Hill JV, Chase JG, Hann CE, Scotter JM, Storer MK, et al. Modelling acute renal failure using blood and breath biomarkers in rats. Comput Methods Programs Biomed. 2011 Feb;101(2):173-82. DOI: 10.1016/j.cmpb.2010.07.01010.1016/j.cmpb.2010.07.01020728235]Search in Google Scholar
[10. Boroujeni NB, Hashemi SM, Khaki Z, Soleimani M. The reversal of hyperglycemia after transplantation of mouse embryonic stem cells induced into early hepatocyte- like cells in streptozotocin-induced diabetic mice. Tissue Cell. 2011 Apr;43(2):75-82. DOI: 10.1016/j. tice.2010.12.002]Search in Google Scholar
[11. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000 Dec;43(12):1528-33. DOI: 10.1007/ s00125005156410.1007/s00125005156411151762]Search in Google Scholar
[12. Eleazu CO, Eleazu KC, Chukwuma S, Essien UN. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord. 2013 Dec;12(1):60. DOI: 10.1186/2251-6581-12-6010.1186/2251-6581-12-60796247424364898]Search in Google Scholar
[13. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med. 1967 Oct;126(1):201-5. DOI: 10.3181/00379727-126-3240110.3181/00379727-126-324014864021]Search in Google Scholar
[14. Huang M, Gao L, Yang L, Lin F, Lei H. Abnormalities in the brain of streptozotocin-induced type 1 diabetic rats revealed by diffusion tensor imaging. Neuroimage Clin. 2012 Sep;1(1):57-65. DOI: 10.1016/j. nicl.2012.09.004]Search in Google Scholar
[15. Ávila Dde L, Araújo GR, Silva M, Miranda PH, Diniz MF, Pedrosa ML, et al. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats. Arch Med Res. 2013 Apr;44(3):194-202. DOI: 10.1016/j.arcmed.2013.03.00410.1016/j.arcmed.2013.03.004]Search in Google Scholar
[16. Yono M, Pouresmail M, Takahashi W, Flanagan JF, Weiss RM, Latifpour J. Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes. Naunyn Schmiedebergs Arch Pharmacol. 2005 Nov;372(3):251-5. DOI: 10.1007/s00210-005-0010-910.1007/s00210-005-0010-9]Search in Google Scholar
[17. Groop PH, Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, et al. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care. 2007 Oct;30(10):2706-7. DOI: 10.2337/dc07-003010.2337/dc07-0030]Search in Google Scholar
[18. Raghunathan S, Tank P, Bhadada S, Patel B. Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications. Biomed Res Int. 2014;2014:948427. DOI: 10.1155/2014/94842710.1155/2014/948427]Search in Google Scholar
[19. Cameron NE, Cotter MA. Diabetes causes an early reduction in autonomic ganglion blood flow in rats. J Diab Complic. 2001 Jul-Aug;15(4):198-202. DOI: 10.1016/S1056-8727(01)00149-010.1016/S1056-8727(01)00149-0]Search in Google Scholar
[20. Obrosova IG, Drel VR, Oltman CL, Mashtalir N, Tibrewala J, Groves JT, et al. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin- diabetic rats. Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1645-55. DOI: 10.1152/ajpendo.00479.200710.1152/ajpendo.00479.200717911342]Search in Google Scholar
[21. Kiba T, Tanaka K, Numata K, Hoshino M, Misugi K, Inoue S. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology. 1996 Mar;110(3):885-93. DOI: 10.1053/gast.1996.v110.pm8608899 10.1053/gast.1996.v110.pm86088998608899]Search in Google Scholar